KGL-50015-78751
3 vaccinations
2 coded responses
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 941 / CA
- Registered
- 2021-11-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-11
Dose 1 — Janssen/Johnson & Johnson
-
2021-10-29
Dose 2 — Pfizer-BioNTech
-
2021-11-02
Registered in v-safe
-
2021-11-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-03
- 2021-11-04
- 2021-11-05
-
2021-11-12
Survey response — day 14, dose 2MedDRA: Nasopharyngitis — Feeling: FairFree text: A cold I think. 3 swab tests were negativeMedDRA releases: 2024-11 · check-in free text available
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2022-01-30
-
2022-04-09
Dose 3 — Pfizer-BioNTech
- 2022-04-29
- 2022-04-30
- 2022-05-07
- 2022-05-16
- 2022-05-21
- 2022-07-09
-
2023-04-09
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-11 | Janssen/Johnson & Johnson | No |
| 2 | 2021-10-29 | Pfizer-BioNTech | No |
| 3 | 2022-04-09 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 2
Symptoms: A cold I think. 3 swab tests were negative
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release